Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2022	Apr. 30, 2022
Current Assets:
Cash and cash equivalents	$ 14,360	$ 4,433
Restricted cash	7,174	2,461
Receivables, less allowance; $371; $357, on each respective date	40,714	41,254
Inventories	25,100	23,796
Note Receivable	0	13,457
Prepaid expenses and other current assets	10,435	6,164
Total Current Assets	97,783	91,565
Property, plant and equipment, at cost	60,716	60,326
Accumulated depreciation	(45,930)	(45,205)
Net Property, Plant and Equipment	14,786	15,121
Right of use assets	8,955	7,573
Other assets	4,119	4,514
Total Assets	125,643	118,773
Current Liabilities:
Short-term borrowings	0	1,588
Current portion of financing liability	591	575
Current portion of financing lease liability	72	126
Current portion of operating lease liabilities	1,685	1,319
Accounts payable	25,042	27,316
Employee compensation and amounts withheld	4,342	4,504
Deferred revenue	14,116	3,529
Other accrued expenses	3,669	3,336
Total Current Liabilities	49,517	42,293
Long-term portion of financing liability	28,618	28,775
Long-term portion of financing lease liability	224	228
Long-term portion of operating lease liabilities	7,142	6,179
Accrued pension and deferred compensation costs	3,989	4,159
Deferred income taxes	451	428
Other non-current liabilities	519	531
Total Liabilities	90,460	82,593
Commitments and Contingencies
Stockholders' Equity:
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,832 shares; 2,793 shares; – Outstanding – 2,829 shares; 2,790 shares, on each respective date	7,080	6,983
Additional paid-in-capital	4,349	4,483
Retained earnings	27,276	28,023
Accumulated other comprehensive loss	(3,966)	(3,742)
Common stock in treasury, at cost, 3 shares, on each respective date	(53)	(53)
Total Kewaunee Scientific Corporation Stockholders' Equity	34,686	35,694
Non-controlling interest	497	486
Total Stockholders' Equity	35,183	36,180
Total Liabilities and Stockholders' Equity	$ 125,643	$ 118,773